Webinar on Stem cell Research, Cell and Gene Therapy organized in Paris, France during July 20, 2020. Stem cell Research , Cell and Gene Therapy Webinar 2020 has extensive sessions in which the main Keynote presentation, YRF (student presentation), Oral, Posters, E-poster presentations. To share their valuable presentation on the most recent and advanced techniques, development and latest updates, a world-renowned speaker and prominent representative representatives from all over the world participate in the conference. On that note, Stem cell Conference 2020 invites all interested participants to this prestigious event in the grand destination Paris, France.
Stem cells market seems to be the constantly trending subject matter with modern day research technologies. Everyone who explores to strengthen their knowledge and gain extended about advanced technical cleverness is welcome to present/get new ideas. We provide a good opportunity by admiring your updated research and also by publishing it in our respective journals. We assure our attendees return to their place with the self-belief to improve their abilities and outfitted with certified approaches to work with us. This meeting will allow the attendees to acquire these new updates and share their experiences with well-recognized speakers globally.
Track 1: Cell Therapy
Cell therapy or cytotherapy is the transfer of cells into a patient with a goal of improving the disease. From beginning blood transfusions were considered to be the first type of cell therapy to be practised as routine. Later, Bone marrow transplantation has also become a well established concept which involves treatment of many kind of blood disorders including anemia, leukaemia, lymphoma and rare immunodeficiency diseases. Alternative medical practitioners perform cell therapy in the form of several different names including xenotransplant therapy glandular therapy, and fresh cell therapy. It has been claimed by the proponents of cell therapy that it has been used successfully to repair spinal cord injuries, strengthen weaken immune system, treats autoimmune diseases like AIDS, help patients with neurological disorders like Alzheimer’s disease, Parkinson’s disease .
Track 2: Gene Therapy
Gene Therapy basically involves the introduction or alteration of genetic material within a cell or organism with an intention of curing the disease. Both cell therapy and gene therapy are overlapping fields of biomedical research with the goals of repairing the direct cause of genetic diseases in DNA or cellular population respectively. The discovery of Recombinant DNA Technology. in the 1970s provided tools to efficiently develop gene therapy. Scientists use these techniques to readily manipulate viral genomes, isolate genes and identify mutations involved in human disease, characterize and regulate gene expressions, and engineer various viral and non-viral vectors. Various long term treatments for anemia, haemophilia, cystic fibrosis, muscular dystrophy, Gauscher’s disease, lysosomal storage diseases, cardiovascular diseases, diabetes and diseases of bones and joints are resolved through successful gene therapy and are elusive toda.
Track 3: Molecular Medicine
Molecular medicine is a branch of medicine that develops ways to diagnose and treat diseases by understanding the ways genes, proteins and other cellular molecules work. It is a broad field where physical, chemical, biological, bioinformatics and medical techniques are used to describe molecular structures and mechanisms, identify fundamental molecular and genetic errors of the disease, and to develop molecular interventions to correct them. Molecular Medicine has now a day proved to be an exciting field of research as some of the recent advancements has led to improved clinical benefits for human health. These are LPS- induced inflammatory response is suppressed by Wnt inhibitors, Dickkopf-1 and LGK974, Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium, ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K-Akt Signalling and many more.
Molecular medicine Conference| Molecular medicine Workshop |Molecular medicine Congress | Molecular medicine Meeting| Molecular medicineSymposium | Molecular medicine Seminar | Molecular medicine Convention
Track 4: Immunotherapy
Due to rapidly advancing field of cancer immunology in past few years, there has been production of several new methods of treating cancer called Immunotherapies. Immunotherapy is a type of treatment that increases the strength of immune response against tumours either by stimulating the activities of specific components of immune system or by counteracting signals produced by cancer cells that suppress immune responses. Some types of immunotherapy are also called as biologic therapy or biotherapy. Recent advancements in cancer immunotherapies have provided new therapeutic approaches. These include tumour-associated macrophages as treatment targets in oncology, in-situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy, immune checkpoint blockade and associated endocrinopathies and many more.
Track 5: Genetic Medicine
Genetic Medicine or Medical Genetics is the branch of medicine that differs from human genetics, and involves the diagnosis and management of hereditary disorders. Human genetics may or may not apply to medicine, but medical genetics refers to the application of genetics to medical care. Genetic Medicine basically involves different areas such as gene therapy, personalized medicine, predictive medicine and the rapidly emerging new medical specialty. Now a days, medical genetics has wide range of scopes in many conditions involving birth defects and dysmorphology, autism, mental retardation, skeletal dysplasia, mitochondrial disorders, cancer genetics, connective tissue disorders and some more.
Track 6: Clinical and Translational Research
According to National institute of health (NIH), Clinical Research is defined in 3 ways i.e. (1) Patient oriented research. Research which is conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. This definition excludes the in vitro studies that utilize human tissues that cannot be linked to a living individual. Patient oriented research involves: (a) therapeutic interventions, (b) mechanisms of human disease, (c) clinical trials, or (d) development of new technologies. (2) Epidemiological and behavioural investigations. (3) Outcomes research and health services research. Translational research on the other hand includes two areas. One is the process of utilizing discoveries generated in the laboratory during research, and in preclinical studies, to the development trials and studies in humans. Second arena of translation concerns on research aimed at enhancing the adoption of best practices in the community. An important part of translational science also includes cost effectiveness of prevention and treatment strategies.
Clinical and Translational Research Conference| Clinical and Translational Research Workshop |Clinical and Translational Research Congress | Clinical and Translational Research Meeting| Clinical and Translational Research Symposium| Clinical and Translational Research Seminar | Clinical and Translational Research Convention
Track 7: Cell Therapy Bioprocessing
Cell Therapy bioprocessing activity mainly focuses to accelerate the safe, cost- effective translations and clinical efficacious of Cell therapies into commercial products. This activity covers the entire range of cell therapy activities as well as tissue engineering. In order to succeed, commercial success of at least a few late-stage products are required to develop which will be funded to develop next generation tools and technologies for this field. Recent achievements include, preclinical filing for Phase 1 clinical trials for cell therapy in acute spinal cord injury, clinical proof of concept studies in tissue- engineered trachea, clinical trials for tissue-engineered larynx and routine clinical practice in the regeneration of corneas. The future research priorities will focus on novel cell and bioprocess engineering techniques in order to improve the manufacturing efficacy and methods for health technology assessment to support rapid clinical adoption of new cell therapies.
Cell Therapy Bioprocessing Conference | Cell Therapy Bioprocessing Workshop |Cell Therapy Bioprocessing Congress | Cell Therapy Bioprocessing Meeting| Cell Therapy Bioprocessing Symposium| Cell Therapy Bioprocessing Seminar | Cell Therapy Bioprocessing Convention
Track 8: Cell & Gene Therapy Development & Production
Cell and Genetherapy products manufacturing focuses on various strategies like the manufacturing process must protect the product, patient, should focus on product characterization, process control, high throughput and parallel processing to achieve scale. The process/analytical development throughout clinical trials involve on going, iterative development of manufacturing process and characterization of profile and FDA expecting increasing control and characterization as clinical development progresses. Steps involved in individualized manufacturing and running in parallel for high throughput involves cell selection, expansion, activation, centrifugation and cryopreservation.
Cell and Gene Therapy Conference | Cell and Gene Therapy Workshop |Cell and Gene Therapy Congress | Cell and Gene Therapy Meeting | Cell and Gene Therapy Symposium| Cell and Gene Therapy Seminar | Cell and Gene Therapy Convention
Track 9: Rare Diseases & Orphan drugs
Rare diseases are life-threatening or chronically debilitating conditions, affecting no more than 5 in 10,000 persons in the European Community according to the Regulation (EC) N. 141/2000 of the European Parliament and of the Council. It is estimated that between 6000 to 8000 distinct rare diseases affect up to 6% of the total EU population. Therefore, these conditions can be considered rare if taken individually but they affect a significant proportion of the European population when considered as a single group. Several initiatives have been taken at international, European and national level to tackle public health as well as research issues related to diagnosis, prevention, treatment and surveillance of these diseases. An Orphan drugcan be defined as the one that is used to treat an Orphan disease. An orphan disease in USA is defined as the one that affects fewer than 200000 individuals, but in Japan the number is 50,000 and in Australia is 2000. In past 20 years efforts have been made to encourage companies to develop orphan drugs. The Orphan Drug Act in the USA (1983) was succeeded by similar legislation in Japan (1985), Australia (1997), and the European Community (2000). The encouragement takes three forms: tax credits and research aids, simplification of marketing authorization procedures, and extended market exclusively.
Track 10: Stem Cell Research and Regenerative Medicine
Stem cells can self-renew themselves and differentiate or develop into more specialised cells. They are the foundation for every organ and tissue in our body. Due to this ability of the stem cells, they have tremendous promise to help us understand and treat a wide range of diseases, injuries and other health related problems. Bone marrow transplantation is the most widely used stem cell therapy, but some of the therapies are derived from umbilical cord blood are also in use today. Likewise, blood stem cells are used to treat diseases of blood, a therapy that has saved thousands of lives of children with leukaemia. Some bone, skin and corneal (eye) injuries and diseases can be treated by grafting or implanting tissues and the healing process relies on stem cells with implanted tissue. Regenerative medicines aims to replace tissues or organs that have been damaged by disease, trauma, or congenital issues which is in contrast to the current clinical strategy that focuses primarily on treating the symptoms. These regenerative medicines have wide appropriateness in treating degenerative scatters including dermatology, cardio vascular, and neuro degenerative diseases. Cell treatment is the quickest developing fragment of regenerative drug and this undeveloped cell treatment is making up the biggest part of this business sector.
Stem cell Research Conference| Stem cell Research Workshop |Stem cell Research Congress | Stem cell Research Meeting| Stem Cell Research Symposium| Stem cell Research Seminar | Stem cell Research Convention
Track 11: Technologies in Stem Cell Research
Stem cell technology is now a days a rapidly emerging field that combines the efforts of cell biologists, clinicians and geneticists. This offers a hope for effective treatment for a variety of malignant and non-malignant diseases. Research has also shown that other than hematopoeticstem cells there are stem cells present in other sites. Hematopoietic stem cells research has made much progress than research in solid tissue stem cells. But the tissue stem cells have proven to be ideal for cell replacement therapy as it has the ability to integrate into the tissue cytoarchitechture under the control of host microenvironment and developmental cues. Moreover, it has also been found that transferring gene into hematopoietic stem cells may allow treatment of genetic diseases. Neurone replacement is done by using neuronal stem cells in disorders such as Parkinson’s and Huntingdon’s diseases. As a result of integrative effort with clinical applications of manipulated stem cells combining developments in transplantation and gene therapy, stem cell technology is advancing.
Technologies in Stem cell Research Conference| Technologies in Stem cell Research Workshop |Technologies in Stem cell ResearchCongress | Technologies in Stem cell Research Meeting| Technologies in Stem cell Research Symposium| Technologies in Stem cell Research Seminar | Technologies in Stem cell Research Convention
Track 12: Cellular and Technological Breakthroughs in Cancer
Cancer is a process where the cells grow aberrantly and this growth of cancer cells results in damage of normal tissues, causing loss of function and often pain. The cancer therapeutic drug are those drugs that block the growth and spread of cancer by interfering with specific molecules (molecular targets) that are involved in the growth, progression and spread of cancer. Moreover, gene therapy approaches may be designed to directly kill tumour cells using tumour killing viruses, or through the introduction of genes termed as suicide genes into the tumour cells. The Food and Drug Administration (FDA) has approved many cancer therapies in order to treat specific types of cancers. To develop targeted therapies it requires the identification of good targets that is, those targets that play a key role in cancer cell growth and survival. One way to identify potential targets is to compare the amounts of individual proteins in cancer cells with those present in normal cells. Gene silencing has also been designed to inhibit the expression of specific genes which are activated or over expressed in cancer cells and can drive tumour growth, blood vessel formation and allow resistance for Chemotherapy.
The global Stem Cell market is expected to grow at an incredible CAGR of 25.5% from 2015 to 2022 and reach a market value of US$297 billion by 2022. The emergence of Induced Pluripotent Stem (iPS) cells as an alternative to ESCs (embryonic stem cells), growth of developing markets, and evolution of new stem cell therapies represent promising growth opportunities for leading players in this sector.
Due to the increased funding from Government and Private sector and rising global awareness about stem cell therapies and research are the main factors which are driving this market. A surge in therapeutic research activities funded by governments across the world has immensely propelled the global stem cells market. However, the high cost of stem cell treatment and stringent government regulations against the harvesting of stem cells are expected to restrain the growth of the global stem cells market.
Whereas the Europe Stem cell market is estimated to grow at a CAGR of 9.45% by the end of the forecast period of 2018-2026. The market is chiefly progressing due to increasing R&D investments in adult stem cell research in the region, ease of administration and the growing incidences of chronic disease due to the changing lifestyles of the population.
The countries analyzed in the Europe Stem cell market are UK, France, Germany, Spain, Italy and rest of Europe. Most of these countries have a stable economic environment, enabling their population to spend more on their health. In this report, the Europe stem cell market has been segmented based on technology, product and applications. At present, the regenerative medicine application accounts for a high revenue share. Because of their use in regenerative therapies, stem cells are increasingly finding applications in the fields of neurological and hematological disorders, and in areas such as organ transplants, Crohn’s disease, systemic lupus, and infertility.
The worldwide Stem cell & regenerative medicines market is functional with several parameters like product type, application, sources, geography and users. In focused to the product type stem cells market is divided into human embryonic stem cells, adult stem cells, IPsec’s, etc. Whereas, regenerative medicines applied the potential of these stem cells to regenerate, repair & replace tissues or the organ which are affected due to injury, natural aging process, and some diseases.
Related Societies and Associations:
- Belgian Society for Stem Cell Research
- UK Stem Cell Foundation
- International Stem Cell Forum
- British Society for Gene and Cell Therapy
- UK Regenerative Medicine Platform
- Austrian Society of Regenerative Medicine
- Scan Balt Stem Cell Research Network
- Student Society for Stem Cell Research
- Norwegian Center for Stem Cell Research
- Lund Stem Cell Center
- Stem Cell Network North Rhine-Westphalia
- UK Stem Cell Bank
- European Group for Blood and Marrow Transplantation
- Israel Stem Cell Society
- Maryland Stem Cell Research Commission
- Harvard College Stem Cell Society
- International Society for Cellular Therapy
- California Institute for Regenerative Medicine
- American Society of Transplantation
- American Society for Matrix Biology
- American Society for Cell Biology
- National Stem Cell Foundation
- Perinatal Stem Cell Society
- International Placenta Stem Cell Society
- American Society for Blood and Marrow Transplantation
- Columbia University Stem Cell Initiative
- The American Regenerative Medicine Society
Asia Pacific and Middle East:
- Hong Kong Stem Cell Society
- Chinese Society for Cell Biology
- Korean Society for Stem Cell Research
- Pakistan Stem Cell Society
- Stem Cell Thai Red Cross
- Iranian Stem Cell Council
- The Japanese Society for Regenerative Medicine
- Formosa Association Regenerative Medicine
- Iranian Society for Hematopoietic Stem Cell Transplantation
- International Society of Regenerative Medicine
- Japan Human Cell Society
Major players for the Stem Cell market are:
- Stem Cell Ge Healthcare
- Becton Dickinson
- Fibrocell Science Inc
- Thermo Fisher Vericel Corporation
- Kangstem Biotech Ltd
- Celgene Corporation
- Biotime Inc
- Corning Inc.
- Corestem Inc
- Brainstorm Cell Therapeutics
- Cytori Therapeutics
- Stemedica Cell Technologies Inc
- Mesoblast Ltd
- Aastrom Biosciences, Inc.
- Celgene Corporation
- StemCells, Inc
Webinar on Stem Cell Research, Cell and Gene Therapy
July 20, 2020 | Paris, France
Young Scientist Awards at Stem Cell 2020 for the Best researches in Stem Cell Research,
Cell and Gene Therapy
Meetings International is announcing Young Scientist Awards through Webinar on Stem Cell Research, Cell and Gene Therapy (Stem Cell 2020 ) which is scheduled at Paris, France during July 20, 2020. This Stem Cell Research Conference focuses on “Bridging the Gap from Basic cell Sciences to Advanced Cellular Therapies for a Better life ”.
Stem cell Research 2020 and upcoming conferences will recognise participants who have significantly added value to the scientific community of environmental science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.
Stem Cell Research 2020 focuses mainly on Cell Therapy, Gene Therapy , Molecular Medicine, Immunotherapy, Genetic Medicine . Stem Cell conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.
Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. candidates. Persons from Scientific Industry can also participate.
Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.
- Acknowledgement as YRF Awardee
- Promotion on the conference website, Young Researcher Awards and certificates
- Link on the conference website
- Recognition on Meetings Int. Award Page
- Chances to coordinate with partners around the world
- Research work can be published in the relevant journal without any publication fee
- All presented abstracts will automatically be considered for the Award.
- All the presentation will be evaluated in the conference venue
- All the awards will be selected by the judges of the award category
- The winners of the Young Scientist Award will receive award certificate.
- The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.
- All submissions must be in English.
- The topic must fit into scientific sessions of the conference
- Each individual participant is allowed to submit maximum 2 papers
- Abstract must be submitted online as per the given abstract template
- Abstracts must be written in Times New Roman and font size will be 12
- Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference
Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.
Official announcement of the recipients will occur after the completion of Stem Cell Conference.
Meetings Int. is a worldwide pioneer in delivering top notch gatherings, workshops and symposia in every significant field of science, innovation and medication worldwide receives 400,000+ online visitors with 1000+ sessionswhich confirm the outstanding pool of new users and visitors creating a platform to build your market place globally. Since its initiation, Meetings Int. has been related with national and global affiliations, organizations and elevated level people, committed to have world class meetings and occasions so its provide a big platform to show your product and advertise.
The explorer’s traffic is the benchmark for advertisement and the Stem Cell website is continually dragged in observer over the world. As specify by the Google Analytics, in excess of 41, 198 Researchers are visiting to our conference sites. Stem Cell help you to put the spotlight on your brand by advertising with more than 9 million+ readers worldwide and about 5 million+ hits every month on our site. We provide a good opportunity to boost your business on our platform. We offer a range of eye-catching advertising spaces and branding. Researchers from significant nations including United States, Japan, United Kingdom, India, France, Taiwan, and Germany visit our conference site. Subscribers and conference attendees can be your upcoming enthusiastic customers. We maintain high quality and ethical standards in event industry, which makes us unique and better than the rest.
Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.
For further queries, connect our Program Manager at:
You can also connect us via WhatsApp: +65 3158 1626 / +44 1250 400 009